StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Sees Early Upside after Massive Beating
March 16, 2016 9:48 AM
After staring lower, Valeant Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Short Sales
Trader Talk
Next Articles
Valeant Pharma (VRX) Price Target Lowered to $45 at TD Securities
March 16, 2016 11:16 AM
Valeant Pharma (VRX) Adds to Gains on Rumor
March 16, 2016 10:12 AM
Valeant (VRX) PT Cut to $40 at Canaccord Genuity
March 16, 2016 9:40 AM
Valeant (VRX) Default 'Unlikely', Says Rodman & Renshaw
March 16, 2016 7:43 AM
Nomura Securities Downgrades Valeant Pharmaceuticals (VRX) to Neutral
March 16, 2016 6:55 AM
